The Singapore Eye Research Institute (SERI) is the national research institute for ophthalmology and vision research in Singapore, affiliated with the National University of Singapore (NUS). SERI is the focal point of eye research in Singapore, serving as the research arm of the Singapore National Eye Centre (SNEC) and other eye departments including the National University Health Systems (NUHS), and Tan Tock Seng Hospital. It has close working relationships with A*STAR, Duke-NUS Graduate Medical School, the Nanyang Technological University and other biomedical institutions and eye centers in Singapore and throughout the world.
Founded in 1997, SERI’s vision is to be a global centre of excellence in eye and vision research in Asia, known internationally for translating basic science to clinical applications for the prevention and treatment of sight threatening eye disorders, particularly those relevant to Asia, such as myopia, glaucoma, corneal disease and diabetic retinopathy. SERI currently has more than 147 staff, comprising a full time faculty of senior scientists and clinician-scientists, supported by post-doctoral fellows and graduate students, clinical trial coordinators and optometrists, epidemiologists, statisticians, and research technicians. In addition, SERI has over 155 adjunct faculties from different eye hospitals and departments in Singapore.
From 1998 to 2009, SERI published 1,012 scientific papers, and had obtained 93 external peer-reviewed competitive grants worth $77.9 million. SERI’s research faculty has been awarded with 100 national and international prizes and 18 patents. A total of 65 Masters, PhD and post-doctoral students have been trained or are currently being trained. SERI staffing has steadily grown from 11 in 1997 to 150 in Nov 2009. An independent article in International Ophthalmology published in November 2008 highlighted Singapore as the world’s leading contributor of publications per population, and SERI contributed approximately 90% of these publications.